Search results for Telisotuzumab
Telisotuzumab Biosimilar – Anti-MET, RCCP2 mAb – Research Grade, ProteoGenix, PX-TA1442
Description of Telisotuzumab Biosimilar - Anti-MET, RCCP2 mAb - Research Grade General information on Anti-MET/RCCP2[Homo sapiens] (Telisotuzumab) Monoclonal Antibody Telisotuzumab is investigated in the treatment of Advanced Solid Tumors.
Host
Reactivity
Applications
Conjugation
Telisotuzumab, Abbexa, abx831399
Telisotuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MET/RCCP2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Telisotuzumab Biosimilar - Research Grade, ichor.bio, ICH5315
Detects human MET
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Telisotuzumab Vedotin Biosimilar - Research Grade, ichor.bio, ICH5315V
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.